Ampio Pharmaceuticals, Inc. (NY:AMPE)

N/A UNCHANGED

Last Price Updated: 8:00 PM EDT, Apr 12, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ampio Pharmaceuticals, Inc.

< Previous 1 2 3 4 5 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 21, 2022

We're starting Wednesday with an overview of the biggest pre-market stock movers this morning and the news moving those shares!

Via InvestorPlace

Why ECMOHO Is Trading Lower By 29%; Here Are 28 Stocks Moving Premarket ↗

September 21, 2022

Gainers Ampio Pharmaceuticals, Inc. (NYSE: AMPE) rose 17.8% to $0.0942 in pre-market trading after declining around 5% on Tuesday.

Via Benzinga

ROSEN, A LONGSTANDING LAW FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

September 17, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Why Kaspien Holdings Is Trading Lower By 13%; Here Are 21 Stocks Moving Premarket ↗

September 14, 2022

Gainers Aditxt, Inc. (NASDAQ: ADTX) rose 54.3% to $28.56 in pre-market trading following effect of 1:50 reverse stock split.

Via Benzinga

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

September 10, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Why Asana Is Trading Higher By 24%; Here Are 24 Stocks Moving Premarket ↗

September 08, 2022

Gainers Asana, Inc. (NYSE: ASAN) rose 24.1% to $23.62 in pre-market trading after the company reported better-than-expected results for its second quarter and issued a strong sales guidance.

Via Benzinga

NYSE:AMPE Investor Notice: Lawsuit Alleges Securities Laws Violations by Ampio Pharmaceuticals, Inc. ↗

September 07, 2022

San Diego, CA -- (SBWIRE) -- 09/07/2022 -- An investor, who purchased shares of Ampio Pharmaceuticals, Inc. (NYSE:AMPE), filed a lawsuit over alleged violations of Federal Securities Laws by Ampio...

Via SBWire

Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket ↗

September 06, 2022

Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday.

Via Benzinga

ROSEN, A TOP RANKED LAW FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

September 05, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Why Lululemon Athletica Is Trading Higher By 11%, Here Are 36 Stocks Moving In Friday's Mid-Day Session ↗

September 02, 2022

Gainers

Via Benzinga

Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday ↗

September 06, 2022

Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

September 02, 2022

We're starting off the final trading day of the week with an overview of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket ↗

September 02, 2022

Gainers

Via Benzinga

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – AMPE

August 29, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

August 27, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. (AMPE)

August 26, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Ampio Pharmaceuticals, Inc. (AMPE) Investors of Class Action and to Actively Participate

August 26, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. (AMPE)

August 24, 2022

From Law Offices of Howard G. Smith

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Ampio Pharmaceuticals, Inc. (AMPE) Investors

August 23, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Ampio Pharmaceuticals, Inc. (AMPE) Investors

August 22, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Ampio Pharmaceuticals, Inc. (AMPE) Investors

August 22, 2022

From Law Offices of Howard G. Smith

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

August 19, 2022

On Friday, 109 stocks hit new 52-week lows.

Via Benzinga

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

August 19, 2022

From The Schall Law Firm

Via Business Wire

AMPIO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ampio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

August 18, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Ampio Pharmaceuticals, Inc. (AMPE) on Behalf of Investors

August 18, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Ampio Pharmaceuticals, Inc. (AMPE) on Behalf of Investors

August 18, 2022

From Law Offices of Howard G. Smith

Via Business Wire

Stockholder Alert: Robbins LLP Reminds Investors it Has Filed a Securities Fraud Lawsuit Against Ampio Pharmaceuticals, Inc.

August 18, 2022

From Robbins LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Ampio Pharmaceuticals, Inc. (AMPE) on Behalf of Investors

August 18, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

August 18, 2022

From The Schall Law Firm

Via Business Wire

EQUITY ALERT: Rosen Law Firm Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMPE

August 18, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.